Xiao Weihua
Professor
Life Science
University of Science and Technology of China
China
Biography
Dr. Xiao received his B.S and PhD. in Medicine from Norman Bethune University, Changchun China, and M.S. in Bioinformatics from Johon Hopkins University, Maryland USA. He was an research associate at Changchun Institute of Biological Products, Changchun, China from 1985 to 1995. He was a postdoctoral fellow under the guidance of Dr. Dhan Kalvakolanu in Cancer Canter at University of Maryland from 1995 to 1998. During 1998-2005, he worked as a scientist at National Cancer Institute, NIH, USA. In the later of 2004, he became a Principle Investigator at Institute of Immunology and School of Life Science in University of Science & Technology of China, and appointed as executive director of the program of medicinal biotechnology and director of GMP Laboratory of Medicinal biotechnology.
Research Interest
Molecular Cancer Biology and Molecular Immunology 1) Signaling transduction and transcription in cancer and immune cells; 2) Inflammation and Cancer Immunity; Medicinal Biotechnology 1) Biological drugs and Immune therapy technology and products development.
Publications
-
Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo. , Lung Cancer. , 2011 , 72(3):287-93
-
In vivo activity of novel anti-ErbB2 antibody chA21 alone and with Paclitaxel or Trastuzumab in breast and ovarian cancer xenograft models , Cancer Immunol Immunother. , 2011 , 60(3):339-48.
-
Reduced expression of ΔÎp63α in cervical squamous cell carcinoma. , Clin Invest Med. , 2011 , 34(3):E184.
